BioSpace News Archive

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, announced the signing of a license agreement with Daiichi Sankyo, a global pharmaceutical company with corporate origins in Japan.

Collaboration Brings Together Gilead’s Commitment to Advancing Cell Therapy with Kyverna’s Focus on Advanced T Cell Engineering Targeting Autoimmune Diseases

Reports 30.5% and 36.7% reduction in triglyceride levels, compared with baseline, among patients receiving CaPre at 12 and 26 weeks respectively, as well as 42.2% reduction in triglyceride levels among patients receiving CaPre while on background statin therapy at 12 weeks

American Academy of Ophthalmology urges people to get smart about eye health in 2020

AbSci announced the completion of a $10.4M Series D financing led by KBI Biopharma and JSR Life Sciences.

Boston IVF, a national leader in reproductive care and fertility research, announced that its Board of Directors has appointed David Stern, MBA as Chief Executive Officer, effective January 6, 2020.

Novocure reported operating statistics and preliminary, unaudited net revenues and cash balances for the fourth quarter and full year 2019.

BriaCell Therapeutics Corp., a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, is pleased to provide an update on the previously-announced top responder in the combination study of its lead candidate, Bria-IMT™, with Incyte’s INCMGA00012, a PD-1 inhibitor.

Surgery Partners, Inc., a leading short-stay surgical facility owner and operator, announced the appointment of Wayne S. DeVeydt to Executive Chairman of the Board of Directors of Surgery Partners, effective immediately.

GenMark Diagnostics, Inc., a leading provider of automated, multiplex molecular diagnostic testing systems, provided preliminary operational and financial results for the year ended December 31, 2019.